Group One Trading
ADMA icon

Group One Trading’s ADMA Biologics ADMA Stock Holding History

Group One Trading’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$49.5K Sell
5,911
-64,272
-92% -$586K ﹤0.01% 5413
2026
Q1 		$632K Sell
70,183
-121,081
-63% -$1.91M ﹤0.01% 3125
2025
Q4 		$3.49M Buy
+191,264
New +$3.22M 0.01% 1804
2023
Q2 		– Sell
-80,127
Closed -$297K – 7584
2023
Q1 		$265K Buy
+80,127
New +$277K ﹤0.01% 3406
2022
Q1 		– Sell
-430,548
Closed -$672K – 7952
2021
Q4 		$607K Buy
430,548
+127,805
+42% +$168K ﹤0.01% 3904
2021
Q3 		$342K Sell
302,743
-68,683
-18% -$96.2K ﹤0.01% 4603
2021
Q2 		$594K Buy
371,426
+56,827
+18% +$100K ﹤0.01% 4026
2021
Q1 		$554K Buy
314,599
+158,282
+101% +$362K ﹤0.01% 3910
2020
Q4 		$305K Buy
156,317
+116,018
+288% +$244K ﹤0.01% 3719
2020
Q3 		$96K Buy
40,299
+24,078
+148% +$66K ﹤0.01% 4217
2020
Q2 		$48K Sell
16,221
-69,864
-81% -$201K ﹤0.01% 4388
2020
Q1 		$248K Sell
86,085
-7,958
-8% -$27.5K ﹤0.01% 2582
2019
Q4 		$376K Buy
94,043
+25,676
+38% +$112K ﹤0.01% 2665
2019
Q3 		$304K Buy
68,367
+46,797
+217% +$196K ﹤0.01% 2756
2019
Q2 		$83K Buy
21,570
+7,870
+57% +$34.7K ﹤0.01% 3484
2019
Q1 		$52K Buy
13,700
+12,900
+1,613% +$45.6K ﹤0.01% 3544
2018
Q4 		$2K Sell
800
-5,900
-88% -$29.2K ﹤0.01% 4636
2018
Q3 		$5K Buy
+6,700
New +$38.6K ﹤0.01% 4816

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Group One Trading's ADMA Position: Q2 2026 in Review

Group One Trading reduced its ADMA Biologics (ADMA) stake by 92% in Q2 2026, selling an estimated $586K and leaving 5,911 shares worth $49.5K. The position accounts for ﹤0.01% of the portfolio, ranked #5413.

Group One Trading first reported a position in ADMA in Q3 2018 and has held it in 18 quarters since. The position peaked at $3.49M in Q4 2025. 322 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Group One Trading held 5,911 shares of ADMA Biologics worth $49.5K as of Q2 2026.
  • Group One Trading sold 64,272 ADMA Biologics shares in Q2 2026, an estimated $586K.
  • ADMA Biologics made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #5413 holding.
  • Group One Trading first reported a position in ADMA Biologics in Q3 2018 and has held it in 18 quarters since.
  • Group One Trading's ADMA Biologics position peaked at $3.49M in Q4 2025.
  • 322 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.